Endo Investor Relations Material
Latest events
Q2 2025
Endo
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Endo Inc
Access all reports
Endo Inc. is a pharmaceutical company engaged in the development, manufacturing, and distribution of branded and generic medicines. The company focuses on a range of therapeutic areas, including pain management, urology, and dermatology. It provides prescription medications, specialty pharmaceuticals, and sterile injectables to healthcare providers and patients. The company is headquartered in Malvern, Pennsylvania, and its shares are listed on the NASDAQ.
Key slides for Endo Inc
Q1 2025
Endo Inc
M&A Announcement
Endo Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NDOI
Country
🇺🇸 United States